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SHORT COMMUNICATION
Low expression of collagen receptors in moderate and poorly
differentiated colorectal adenocarcinomas
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Collagens are major components of the extracellular matrix
(ECM) and can influence polarity, proliferation and
differentiation of epithelial cells (Reddi, 1984). Specific recep-
tors for collagens and other ECM proteins have recently
been identified on various normal and transformed cells
(Hemler, 1988; Wayner and Carter, 1987). These receptors
may mediate the effects of collagens on cell proliferation and
differentiation by acting as transducers of signals between the
collagen matrix and the cytoskeleton (Bissell et al., 1982).
We have recently shown that colon tumour cells in culture
become unresponsive to the differentiating signals of collagen
and acquire an uncontrolled pattern of growth, due in part
to loss of a specific cell surface collagen receptor (Pignatelli &
Bodmer, 1988). We now have preliminary evidence suggest-
ing that the collagen receptor described belongs to the inte-
grin family of ECM receptors which are axp heterodimeric
transmembrane proteins divided into three subfamilies (PI, P2.
and P3) based on the sharing of a common P chain (Hynes,
1987; Ruoslahti & Piershbacher, 1987). At least two integrin
collagen receptors, VLA-2 (2011) and VLA-3 (03p), charac-
terised by affinity chromatography and by inhibition of cell
adhesion to collagen by specific monoclonal antibodies
(Wayner & Carter, 1987), are normally expressed by epithelial
cells (Wayner et al., 1988). Lack of these and other similar
receptors could therefore be strongly selected for in tumour
cells and their loss could constitute major steps towards an
indifferentiated pattern of growth (Bodmer, 1988).
Here we report data showing a progressive loss of the 13
chain and of the a2 and o3 chains of the two known integrin
collagen receptors VLA-2 and VLA-3 respectively (Wayner &
Carter, 1987; Wayner et al., 1988), associated with a loss of
tumour differentiation in patients with colorectal adenocar-
cinoma. Cryostat sections from four adenomas, 24 colorectal
adenocarcinomas and the adjacent macroscopically normal
colonic mucosa (10 cm from the primary tumour) were
stained by an indirect immunoperoxidase technique using the
DH12, B1.515 and E1.56 mouse monoclonal antibodies.
DH12 reacts with the human PI integrin chain in western
blot, immunoprecipitation and immunohistochemistry (De
Strooper et al., 1988, 1989) and was a generous gift of Dr
Bart De Strooper (University of Leuven, Belgium). It was
obtained as ascites fluid and used at 20jg ml-' concentration
in phosphate buffered saline (PBS). B1.515 reacts with the a2
chain of human VLA-2 and E1.56 with the a3 chain of
human VLA-3 by immunoprecipitation and immunohisto-
chemistry (Pischel et al., 1987, 1988). B1.515 and E1.56
monoclonal antibodies were a generous gift of Dr Ken Pis-
chel (University of California, San Diego, USA). Both
B1.515 and E1.56 were obtained in purified form, diluted
with PBS and used at 20 g ml-' concentration. Cryostat
sections (61im) were fixed in acetone for 10min and then
washed in PBS. Sections were then incubated with 20 l of
each monoclonal antibody for 60 min in a humidified
chamber, washed three times in PBS and incubated for
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45 min with peroxidase-conjugated rabbit anti-mouse
immunoglobulin (Dako, Denmark). The reaction product
was developed in diaminobenzidine and counterstained with
haematoxylin. Control sections were incubated with either
the peroxidase conjugated antibody or the diaminobenzidine
solution alone. Non-specific staining by these reagents was
not observed. The proportion of tumour cells stained by each
monoclonal antibody was assessed semi-quantitatively as fol-
lows: 1, <50% positive tumour cells; 2, > 50% but <95%;
3, >95% positive tumour cells. The intensity of the staining
was also scored arbitrarly as follows: +, strong; -, weak.
The sections were evaluated by two examiners (M.P. and
M.E.F.S.) with no significant interobserver variation.
All three monoclonal antibodies showed a strong mem-
brane and cytoplasmic staining with normal colonic epithelial
cells (columnar and goblet cells) (Figures la, 2a and 3a).
Smooth muscle cells were also positive with all antibodies
whereas venule endothelial cells showed a strong reactivity
only with the anti-pi (DH12) and the anti-a3 (E1.56) integrin
chain monoclonal antibodies. Both VLA-2 (a2PI) and VLA-3
(oX3PI) heterodimers were detected on the entire plasma mem-
brane of colon epithelial cells, as shown in Figures la, 2a and
3a. This is in agreement with recent reports showing that
VLA-2 is localised over the basal and apical lateral surface of
epidermal, tonsilar, respiratory and gastrointestinal epithelial
cells (Zutter & Santoro, 1989) and VLA-3 is also strongly
expressed on the entire plasma membrane of at least kidney
glomeruli and basal cells of the epidermis (Klein et al., 1987).
The cytoplasmic localisation of integral membrane proteins
such as VLA-2 and VLA-3 may be due to an intracellular
pool of mature a and P chains (Heino et al., 1989) or, at least
for the PI integrin subunit, to the known reactivity of the
DH12 monoclonal antibody with the intracellular precursor
of the 1, chain (Jaspers et al., 1988).
In 4/4 adenomas and 5/6 well differentiated adenocar-
cinomas we found a strong expression of all three chains, 13,,
M2 and a3, with no significant difference in intensity compared
to the normal colonic mucosa (Table I). In 8/14 moderately
differentiated and in 3/4 poorly differentiated tumours the
expression of the three chains was markedly altered, showing
a variety of patterns of reactivity (Figures lb, 2b and 3b).
The difference between the adenomas and well differentiated
adenocarcinomas as compared to the moderately and poorly
differentiated adenocarcinomas was statistically significant
with (P <0.02 (X2 = 5.6). There was either a diffuse reduc-
tion in staining intensity as compared to the normal
epithelium (cases nos 8, 12, 18, 21 and 23) (Figure 2b shows
case no. 8) or a more heterogenous pattern with a reduced
percentage of tumour cells (from 80% to as low as 25%)
staining positive. In most cases reactivity to all three
antibodies was changed to about the same extent. Negative
tumour cells were mainly localised to the undifferentiated
sections of the tumour whereas the lining epithelium in direct
contact with the stroma showed strong membrane staining
(cases nos 7, 11, 14, 20 and 24) (Figure lb shows case no. 7
and Figure-3b case no. 11). We did not find any correlation
between the expression of 13I, a2 or E3 chains and Dukes'
stage (Table I).
In conclusion, we have shown that low expression of the
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Figure 1 Expression ot the P, integrin chain in normal colonic
mucosa (a) and in a moderate differentiated colorectal adenocar-
cinoma (case no. 7) (b) by indirect immunoperoxidase staining
using the DH12 monoclonal antibody (bar =20jAm). 0,*¢!1*hi
p6R.-_..... RMM .....-.......... _ -_ ..
Figure 3 Expression of the a3 chain of the VLA-3 integrin
collagen receptor in normal colonic mucosa (a) and in a
moderate differentiated colorectal adenocarcinoma (case no. 11)
(b) by indirect immunoperoxidase staining using the E1.56
(bar = 20 ltm).
Table I Expression of P,, a2 and a3 integrin chains in four
adenomas and 24 colorectal adenocarcinomas
W 5T-~~.1
Figure 2 Expression of the a2 chain of the VLA-2 integrin
collagen receptor in normal colonic mucosa (a) and in a
moderate differentiated colorectal adenocarcinoma (case no. 8)
(b) by indirect immunoperoxidase staining using the Bl.515





































































































































































The percentage of positive tumour cells were scored as follows:
I = less than 50% positive tumour cells, 2 = between 51% and 95%
positive tumour cells, 3 = over 95% positive tumour cells. Staining
intensity: + strong, - weak. *Normal tissue not available.
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,B,, a2 and M3 chains of the VLA-2 and VLA-3 integrin
receptors occurs relatively frequently in colorectal adenocar-
cinomas and is associated with a loss of tumour
differentiation. The morphological assessment of the gland-
ular configuration and evaluation of the preserved nuclear
polarity where cell base and apex are readily distinguished
are the most reliable criteria to define the grade of malig-
nancy of colorectal tumours (Jass et al., 1986). The establish-
ment and maintenance of a polarised and differentiated
epithelial cell phenotype is a multistage process that appears
to depend on the expression of proteins mediating
cell-matrix and cell-cell interactions (Boulan & Nelson,
1989). Since it has been suggested that both VLA-2 and
VLA-3 may be involved not only in cell-matrix but also in
cell-cell interaction (Kaufmann et al., 1989; Zutter & San-
toro, 1989), our findings may, at least in part, explain the
morphological changes towards a more undifferentiated and
malignant phenotype occurring in colorectal cancer. Direct
expression of cell adhesion molecules mediating mor-
phological differentiation would probably limit the growth
potential of a developing tumour because of the inverse
relationship between growth and differentiation. Escape from
this control of differentiation through loss of ability to syn-
thesise cell adhesion molecules will be strongly favoured by
selection and may contribute to the uncontrolled pattern of
growth typical of malignant neoplasia (Bodmer, 1988).
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